Data / Form D filings / Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc.: Form D filings
Paradigm Diagnostics, Inc., a pharmaceuticals company in Phoenix, AZ, filed 4 Form D notices with the SEC between 2016 and 2018. The latest, on December 4, 2018, reports $11 million sold of a $12.5 million offering to 12 investors.
Find out what Paradigm Diagnostics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 445 N. 5TH STREET, SUITE 300, Phoenix, AZ, 85004
- Phone
- (602) 850-7000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1690852
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2018 | Amendment | $12,500,000 | $10,979,989 | $1,520,011 | 12 | Nov 16, 2016 | sec.gov |
| Jul 3, 2018 | Amendment | $10,500,000 | $8,929,993 | $1,570,007 | 10 | Nov 16, 2016 | sec.gov |
| Dec 11, 2017 | Amendment | $8,999,998 | $7,399,997 | $1,600,001 | 6 | Nov 16, 2016 | sec.gov |
| Dec 2, 2016 | New notice | $7,000,000 | $3,500,000 | $3,500,000 | 4 | Nov 16, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Grace Colon | Director | |
| Scott Morris | Executive Officer | |
| David Neal | Executive Officer | |
| David Mallery | Executive Officer, Director | |
| Erin Curley | Director | |
| Carey Ng | Director | |
| Robert Armknecht | Director | |
| Rodney Markin | Director |
Every Form D from the week of Dec 3, 2018 · All recent filings in Arizona · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Paradigm Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.